Prkačin, I.; Brkić, A.; Pondeljak, N.; Mokos, M.; Gaćina, K.; Šitum, M.
Adjuvant Immunotherapy in Stage IIB/IIC Melanoma: Current Evidence and Future Directions. Biomedicines 2025, 13, 1894.
https://doi.org/10.3390/biomedicines13081894
AMA Style
Prkačin I, Brkić A, Pondeljak N, Mokos M, Gaćina K, Šitum M.
Adjuvant Immunotherapy in Stage IIB/IIC Melanoma: Current Evidence and Future Directions. Biomedicines. 2025; 13(8):1894.
https://doi.org/10.3390/biomedicines13081894
Chicago/Turabian Style
Prkačin, Ivana, Ana Brkić, Nives Pondeljak, Mislav Mokos, Klara Gaćina, and Mirna Šitum.
2025. "Adjuvant Immunotherapy in Stage IIB/IIC Melanoma: Current Evidence and Future Directions" Biomedicines 13, no. 8: 1894.
https://doi.org/10.3390/biomedicines13081894
APA Style
Prkačin, I., Brkić, A., Pondeljak, N., Mokos, M., Gaćina, K., & Šitum, M.
(2025). Adjuvant Immunotherapy in Stage IIB/IIC Melanoma: Current Evidence and Future Directions. Biomedicines, 13(8), 1894.
https://doi.org/10.3390/biomedicines13081894